Media center

30 June 2025 - The International Planned Parenthood Federation (IPPF) is proud to announce the roll out of CAB-LA (cabotegravir-long acting), a form of pre-exposure prophylaxis (PrEP) for HIV, in Eswatini, and Malawi, and a pilot project in Lesotho - a major milestone in the fight against HIV. IPPF Member Associations (MAs) in the three countries - Family Life Association of Eswatini (FLAS), Lesotho Planned Parenthood Association (LPPA), and Family Planning Association of Malawi ( FPAM) will soon begin to distribute CAB-LA for HIV prevention to individuals who would like to use this form of HIV prevention.  CAB-LA, a long-acting injectable PrEP, is a game changer for HIV prevention. PrEP is an HIV prevention method where HIV-negative individuals take medication to significantly reduce their risk of acquiring HIV. Administered every 8 weeks, CAB-LA greatly reduces infection risk and does not rely on remembering to take a daily pill, addressing adherence challenges faced by some people using oral PrEP.  This roll-out comes when US budget cuts have severely impacted governments and organizations providing sexual and reproductive health services, HIV prevention, and humanitarian aid. These financial restrictions have significantly impacted access to essential sexual and reproductive health medications globally, compromising HIV prevention and treatment for many, especially those most in need. The arrival of CAB-LA is a major step forward in the fight against HIV/AIDS, providing longer-term protection, a more convenient option, and a discreet alternative to daily pills. Family Life Association of Eswatini, Lesotho Planned Parenthood Association, and the Family Planning Association of Malawi will be providing CAB-LA for PrEP through their static clinics and other public service delivery points. This effort underscores the vital role our MAs play in securing and delivering universal access to sexual and reproductive healthcare. For more information, please contact media@ippf.orgAbout the International Planned Parenthood Federation  IPPF is a global healthcare provider and a leading advocate of sexual and reproductive health and rights (SRHR) for all. Led by a courageous and determined group of women, IPPF was founded in 1952 at the Third International Planned Parenthood Conference. Today, we are a movement of 158 Member Associations and Collaborative Partners with a presence in over 153 countries.  Our work is wide-ranging, and includes services for sexual health and well-being, contraception, abortion care, sexually transmitted infections and reproductive tract infections, HIV, obstetrics and gynecology, fertility support, sexual and gender-based violence, comprehensive sex education, and responding to humanitarian crises. We pride ourselves on being local through our members and global through our network. At the heart of our mission is the provision of – and advocacy in support of – integrated healthcare to anyone who needs it regardless of race, gender, sex, income, and, crucially no matter how remote.  

The recent approval of Japan's first oral abortion pill is an important step towards achieving gender equality and ensuring that women exercise their right to self-determination over their bodies, including pregnancy and childbirth. IPPF believes that true gender equality requires empowering women to be fully informed and in control of their bodies, thereby expanding their choices and enabling them to determine their own futures. Dr Alvaro Bermejo, Director General of the International Planned Parenthood Federation (IPPF), underlined the importance of this landmark milestone during a visit to Japan in April. Public support through public comments for the approval shows that the social situation in Japan is changing, with increased awareness of women's lives and health, reproductive freedom and women's rights. In its guidelines, the World Health Organisation (WHO) included oral abortion pills in the Essential Medicines Core List, in line with the evidence accumulated in the past, and removed the requirement of direct supervision by health professionals for their use as these pills can be used outside healthcare facilities without compromising safety and efficacy and the abortion process can be managed using the drug without direct supervision of health professionals. IPPF urges Japan to follow these WHO guidelines, including abortion as part of women's health care, and allow women to take safe oral abortion pills at home. Guaranteeing women in its own country access to these essential medicines is also in line with Japan's strong commitment and global pledge to achieve Universal Health Coverage (UHC), ensuring that all women have access to medicines that save their health and lives, and that no one is left behind. IPPF looks forward to, and is committed to working with and supporting, Japan's future steps towards achieving a society that supports true gender equality, where women can exercise their right to self-determination over reproduction.